Loading...

VRNA VERONA PHARMA PLC US FDA Inspections 8-K Filing

VRN

VRN

VERONA PHARMA PLC

(VRNA)

2023 8-K

Show Summary

Show Summary

Financial Statements

Credit Agreement Amendment

Financial Results

Financial Results

Financial Results

Financial Results Announcement

Financial Results

Financial Results Announcement

Management Changes

Term Loan Facility

Dismissal of Independent Au...

Results of Operations and F...

Other Special Situation

Sublease Agreement and Dire...

Financial Results Announcement

Earnings Reports

AGM Approval of Incentive A...

Financial Results Announcement

External Links:

Verona Pharma announced that the FDA has accepted their NDA for ensifentrine for the treatment of COPD.

AI Assistant

VERONA PHARMA PLC

2023

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.